Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions
Virginie Lemiale, Sandrine Valade, Eric Mariotte Medical Intensive Care Unit, Saint Louis University Hospital, Assistance Publique des Hôpitaux de Paris, Paris, FranceCorrespondence: Eric MariotteMedical Intensive Care Unit, Saint Louis University Hospital, Assistance Publique des H&oc...
Main Authors: | Lemiale V, Valade S, Mariotte E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/unresponsive-thrombotic-thrombocytopenic-purpura-ttp-challenges-and-so-peer-reviewed-fulltext-article-TCRM |
Similar Items
-
Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship
by: Senthil Sukumar, et al.
Published: (2021-12-01) -
Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
by: Mouhamed Yazan Abou-Ismail, et al.
Published: (2020-10-01) -
Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes
by: Kucukyurt S, et al.
Published: (2020-09-01) -
Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution
by: Constantine N. Logothetis, et al.
Published: (2021-07-01) -
Rituximab Twice Weekly for Refractory Thrombotic Thrombocytopenic Purpura in a Critically Ill Patient with Acute Respiratory Distress Syndrome
by: Bahjat Azrieh, et al.
Published: (2020-02-01)